Posted in Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA, Equipments, Exosomes, Isotypes, Medium & Serums, NATtrol, Pcr Kits, Peptides, Recombinant Proteins, Ria Kits, RNA, Test Kits
Human Cytomegalovirus-Encoded microRNAs Can Be Found in Saliva Samples from Renal Transplant Recipients
The human cytomegalovirus infection (HCMV) is general after kidney transplants and may have a long-term effect. HCMV can be measured directly by DNA virus or indirectly through the host of the immune response. Microrna encoded HCMV (MIRNA) can change the pathobiology of HCMV infection and contribute to the development of HCMV. MIRNAS encoded HCMV can be detected in the blood but has not been sought with saliva. We investigate the samples of saliva from 32 recipients of kidney transplant (RTR) and 12 seropositive health controls for whom immunological data is available.
Five Mirnas encoded HCMV (MIR-UL112-5P, MIR-US5-2-3P, MIR-UL36, MIR-US25-2-3P and MIR-UL22A) are searched using the primary probe test. HCMV Mirna species detected in saliva from 15 RTR and 3 healthy controls, with the most commonly detected MIR-US5-2-3P. The presence of HCMV MInnas is related to an increase in the T-cell response to HCMV IE-1 on RTR, shows a frequent reactive link from HCMV.
Cytomegalovirus endotheliitis after penetrating keratoplasty
Cytomegalovirus (CMV) – The chain corneal endothelial is the inflammation of the corneal endothelia caused by CMV. This can happen de novo or after ocular surgery in healthy individuals. In patients who have undergone Keratoplasty, the diagnosis of appealing viral endotheliitis and the rejection of the graft regarding the immune system challenges because of similar clinical findings.
Here we report a patient who underwent keratoplasty penetrating and using local and systemic immunosuppressive agents because of the history of the previous graft rejection. In the 4th postoperative, eye examination revealed local corneal edema, coin-shaped kereal deposits, and increased intraocular pressure, consistent with viral endotheliitis. The polymerase chain reaction reveals CMV-DNA amplification in aqueous humor sample. Valganciclovir treatment began and the symptoms improved in 2 months. It must be remembered that local or systemic immunosuppressants are used after keratoplasty can trigger CMV reactivation. Anti-CMV treatment must begin immediately in patients with coin-shaped keratic deposits.
Cytomegalovirus (CMV) management in alogenic hematopoietic cell transplants: Predictor pre-transplant survival, reactivation and spontaneous permits
Cytomegalovirus (CMV) reactivation is a complication that often occurs after alogenic hematopoietic cell transplants (ALLOHCT). We analyzed 159 ALLOHCT receivers with 4409 quantitative viral viral to determine the pre-transplanted predictor of CMV reactivation, clinically significant CMV infection (CS-CMVI, defined as Viral Load CMV> 1000 IU / ml), CMV disease, spontaneous cmv cleaning kinetics and survival Using a standard pre-emptive therapy approach to identify risk groups to target prevention strategies.
The most common CS-CMVI in non-related donor donor transplants (URD). Spontaneous CMV permits occurred in 26% of patients who reached Viral Load 56-137 IU / ML, 6% in 138-250 IU / ML and in 1 patient> 250 IU / ml. The median time between the first CMV reactivation (> 56 IU / ML) and Viral Load> 250 IU / ML is 13 days, while the time from the first viral load> 250 IU / ML to reach the Loading Vial> 1000 IU / ML 4 days. CS-CMVI is associated with a significant increase in non-relapse mortality (NRM) in multivariate analysis. Overall, this study shows that URD D / R + recipients are at high risk for mortality related CSVI and CMV, and are potential candidates for targeted CMV prophylaxis. CMV spontaneous cleaning outside the 250 IU / ML viral load is rare, indicating that this can be used as the appropriate threshold for starting pre-emptive therapy.

Cytomegalovirus-specific-specific-t-cell-specific-specific-cell receptor receptor after the alogenic stem cell transplantation
Cytomegalovirus (CMV) infection is the main complication during the alogenic stem cell transplantation (allo-sct). However, the mechanism of adaptive immunity which encourages this remains unclear. To define the initial immunological response against CMV after transplantation, we use the next generation sequencing to check the CD8 + / CMV Tetramer + cell (CMV-CCV) cell receptor (CMV-CTLS) in a peripheral blood sample obtained from 16 Allo-SCT receivers with HLA , -A * 24: 02 at the time of CMV reactivation.
In most patients, TCR Beta CMV-CTLS repertoar is very tilted (Median Inverse Simpson’s Index: 1,595) and, 15 of the 16 patients sharing at least one TCR-beta clone with ≥ 2 patients. TCR shared dominant in 12 patients and, two clonotypes were divided around half of the patients. The similarity analysis shows that CDR3 sequences from TCR together are more similar than TCR which is not divided. TCR beta repertoir from CMV-CTL in 12 patients was also analyzed after 2-4 weeks to characterize the short-term dynamics of the TCR repertoire. In ten patients, we observe the persistence of applicable clones. In two other patients, the TCR repertoire became more diverse, the main clone declined, and new private clones later emerged. These results provide substantive instructions to understand immunological behavior towards CMV reactivation after allo-sct.
Protein kinase autophagy-initiate ulk1 phosphorylation human cytomegalovirus tegument protein pp28 and regulate the release of an efficient virus
Autophagy is a catabolic process that contributes to intrinsic cellular defense by degrading viral or protein particles, but some viruses hijack this path for their own benefit. The role of autophagy during the replication of human cytomegalovirus (HCMV) has not been clarified earlier. Utilizing Sirna-based filtering, we observed that the depletion of many autophagy related proteins resulted in reduced virus releases showing the requirements of autophagy related factors for efficient HCMV replication.
In addition, we can show that the autophagy-initiation of Serine / Threonine-Protein Kinase ULK1 and other constituents of the UK1 complex have been regulated during the initial infection and remain regulated throughout the replication cycle. We show that indirect disturbances with ULK1 through the inhibition of the release of the UPSTRAM regulator regulator Virus Regulator. Furthermore, this result is verified by the direct revocation of Ulk1 Kinase activity that uses the Special Kinase Inhibitor Ulk1 SBI-0206965 and ULK-101.
Analysis of viral protein expression with the existence of an ULK-101 revealed the connection between the cellular kinase ULK1 and Viral Tegument Protein PP28 (Pul999) and we identified PP28 as a novel virus substrate with a vitro kinase test. In the absence of ulk1 kinase activity, a large PP28- and PP65-positive structure can be detected in the cytoplasm at the end point of the infection.
NFκB-p65 Polyclonal Antibody |
41733-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41733-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41808-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41808-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41227-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41227-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41228-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41228-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41229-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41229-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41230-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41230-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41231-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41231-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41232-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41232-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41233-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41233-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41234-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41234-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41235-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41235-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41236-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41236-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 Polyclonal Antibody |
41237-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 Polyclonal Antibody |
41237-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB -p65 (Ab-435) Conjugated Antibody |
C21012 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65 (Ab-254) Antibody |
21010-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-254) Antibody |
21010-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-276) Antibody |
21011-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-276) Antibody |
21011-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-468) Antibody |
21013-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-468) Antibody |
21013-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-536) Antibody |
21014-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-536) Antibody |
21014-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-505) Antibody |
21178-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-505) Antibody |
21178-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-529) Antibody |
21210-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-529) Antibody |
21210-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-311) Antibody |
21252-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Ab-311) Antibody |
21252-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65((phospho-Ser311) Antibody |
11260-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65((phospho-Ser311) Antibody |
11260-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Phospho-Thr505) Antibody |
11166-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Phospho-Thr505) Antibody |
11166-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Phospho-Ser529) Antibody |
11217-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Phospho-Ser529) Antibody |
11217-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Phospho-Thr254) Antibody |
11010-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Phospho-Thr254) Antibody |
11010-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65(Phospho-Ser276) Antibody |
11011-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65(Phospho-Ser276) Antibody |
11011-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65(Phospho-Thr435) Antibody |
11012-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65(Phospho-Thr435) Antibody |
11012-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65(Phospho-Ser468) Antibody |
11013-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65(Phospho-Ser468) Antibody |
11013-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Phospho-Ser536) Antibody |
11014-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Phospho-Ser536) Antibody |
11014-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Ab-254) Conjugated Antibody |
C21010 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65 (Acetyl-Lys310) Polyclonal Antibody |
HW110-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Acetyl-Lys310) Polyclonal Antibody |
HW110-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Acetyl-Lys218) Polyclonal Antibody |
HW122-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Acetyl-Lys218) Polyclonal Antibody |
HW122-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Acetyl-Lys122) Polyclonal Antibody |
HW148-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Acetyl-Lys122) Polyclonal Antibody |
HW148-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Acetyl-Lys221) Polyclonal Antibody |
HW149-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Acetyl-Lys221) Polyclonal Antibody |
HW149-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Acetyl-Lys314/Lys315) Polyclonal Antibody |
HW136-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Acetyl-Lys314/Lys315) Polyclonal Antibody |
HW136-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65(Phospho-Thr435) Polyclonal Conjugated Antibody |
C11012 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65(Phospho-Ser468) Polyclonal Conjugated Antibody |
C11013 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65 (Phospho-Thr505) Polyclonal Conjugated Antibody |
C11166 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65((phospho-Ser311) Polyclonal Conjugated Antibody |
C11260 |
SAB |
100ul |
EUR 476.4 |
NFκB-p65 (Mono-Methyl-Lys314/Lys315) Polyclonal Antibody |
HW105-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p65 (Mono-Methyl-Lys314/Lys315) Polyclonal Antibody |
HW105-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p65 (Mono-Methyl-Lys314/Lys315) Polyclonal Conjugated Antibody |
CHW105 |
SAB |
100ul |
EUR 476.4 |
NF-κB p65 Antibody |
48498-100ul |
SAB |
100ul |
EUR 399.6 |
NF-κB p65 Antibody |
48498-50ul |
SAB |
50ul |
EUR 286.8 |
NFκB-p105/p50 Polyclonal Antibody |
41226-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 Polyclonal Antibody |
41226-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Ab-927) Antibody |
21312-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Ab-927) Antibody |
21312-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52 (Ab-866) Antibody |
21015-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100/p52 (Ab-866) Antibody |
21015-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52 (Ab-870) Antibody |
21016-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100/p52 (Ab-870) Antibody |
21016-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Ab-337) Antibody |
21017-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Ab-337) Antibody |
21017-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Ab-893) Antibody |
21018-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Ab-893) Antibody |
21018-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Ab-907) Antibody |
21019-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Ab-907) Antibody |
21019-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Ab-932) Antibody |
21243-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Ab-932) Antibody |
21243-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52 (Ab-872) Antibody |
21297-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100/p52 (Ab-872) Antibody |
21297-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Phospho-Ser932) Antibody |
11251-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Phospho-Ser932) Antibody |
11251-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50 (Phospho-Ser927) Antibody |
11312-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50 (Phospho-Ser927) Antibody |
11312-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52(Phospho-Ser866) Antibody |
11015-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100/p52(Phospho-Ser866) Antibody |
11015-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52(Phospho-Ser870) Antibody |
11016-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100/p52(Phospho-Ser870) Antibody |
11016-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50(Phospho-Ser337) Antibody |
11017-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50(Phospho-Ser337) Antibody |
11017-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50(Phospho-Ser893) Antibody |
11018-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50(Phospho-Ser893) Antibody |
11018-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105/p50(Phospho-Ser907) Antibody |
11019-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105/p50(Phospho-Ser907) Antibody |
11019-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100 Polyclonal Antibody |
41224-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p100 Polyclonal Antibody |
41224-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p105 Polyclonal Antibody |
41225-100ul |
SAB |
100ul |
EUR 302.4 |
NFκB-p105 Polyclonal Antibody |
41225-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100/p52 (Ab-866) Conjugated Antibody |
C21015 |
SAB |
100ul |
EUR 476.4 |
NFκB-p105/p50 (Ab-337) Conjugated Antibody |
C21017 |
SAB |
100ul |
EUR 476.4 |
NF-κB p65 (Ab-311) Antibody |
33198-100ul |
SAB |
100ul |
EUR 302.4 |
NF-κB p65 (Ab-311) Antibody |
33198-50ul |
SAB |
50ul |
EUR 224.4 |
NFκB-p100 Polyclonal Conjugated Antibody |
C41224 |
SAB |
100ul |
EUR 476.4 |
Monoclonal NF-κB p65 Antibody, Clone: 6H7 |
APR08725G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human NF-κB p65. The antibodies are raised in Mouse and are from clone 6H7. This antibody is applicable in WB, E |
NFκB-p105 (Ab-893) Conjugated Antibody |
C21018 |
SAB |
100ul |
EUR 476.4 |
NFκB-p100/p52(Phospho-Ser866) Polyclonal Conjugated Antibody |
C11015 |
SAB |
100ul |
EUR 476.4 |
NFκB-p100/p52(Phospho-Ser870) Polyclonal Conjugated Antibody |
C11016 |
SAB |
100ul |
EUR 476.4 |
NFκB-p105/p50(Phospho-Ser337) Polyclonal Conjugated Antibody |
C11017 |
SAB |
100ul |
EUR 476.4 |
NFκB-p105/p50(Phospho-Ser893) Polyclonal Conjugated Antibody |
C11018 |
SAB |
100ul |
EUR 476.4 |
NFκB-p105/p50(Phospho-Ser907) Polyclonal Conjugated Antibody |
C11019 |
SAB |
100ul |
EUR 476.4 |
NF-κB p65 (Ab-311) Conjugated Antibody |
C33198 |
SAB |
100ul |
EUR 476.4 |
NFκB-p105(Phospho-Ser927) Polyclonal Conjugated Antibody |
C11312 |
SAB |
100ul |
EUR 476.4 |
Acetyl-NFκB-p65 (Lys314/315) Antibody |
AF3795 |
Affbiotech |
100ul |
EUR 420 |
Rat nuclear factor-κB p65, NF-κB p65 ELISA Kit |
CSB-E08788r-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Rat nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Rat nuclear factor-κB p65, NF-κB p65 ELISA Kit |
1-CSB-E08788r |
Cusabio |
-
EUR 1160.40
-
EUR 7110.00
-
EUR 3760.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Rat nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rat nuclear factor-κB p65,NF-κB p65 ELISA Kit |
CN-01728R1 |
ChemNorm |
96T |
EUR 572.4 |
Rat NF-κB p65(Nuclear Factor-κB P65) ELISA Kit |
ER1187 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 46.875pg/ml |
Rat nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0298RT-48T |
GenAsia Biotech |
48T |
EUR 380.4 |
Rat nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0298RT-96T |
GenAsia Biotech |
96T |
EUR 595.2 |
Human nuclear factor-κB p65, NF-κB p65 ELISA Kit |
CSB-E08787h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Human nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human nuclear factor-κB p65, NF-κB p65 ELISA Kit |
1-CSB-E08787h |
Cusabio |
-
EUR 843.60
-
EUR 5811.60
-
EUR 3084.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse nuclear factor-κB p65, NF-κB p65 ELISA Kit |
CSB-E08789m-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse nuclear factor-κB p65, NF-κB p65 ELISA Kit |
1-CSB-E08789m |
Cusabio |
-
EUR 843.60
-
EUR 5811.60
-
EUR 3084.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse nuclear factor-κB p65, NF-κB p65 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse nuclear factor-κB p65,NF-κB p65 ELISA Kit |
CN-02606M1 |
ChemNorm |
96T |
EUR 523.2 |
Mouse nuclear factor-κB p65,NF-κB p65 ELISA Kit |
CN-02606M2 |
ChemNorm |
48T |
EUR 344.4 |
Human nuclear factor-κB p65,NF-κB p65 ELISA Kit |
CN-03540H1 |
ChemNorm |
96T |
EUR 573.6 |
Human nuclear factor-κB p65,NF-κB p65 ELISA Kit |
CN-03540H2 |
ChemNorm |
48T |
EUR 394.8 |
Mouse NF-κB p65(Nuclear Factor-κB p65) ELISA Kit |
EM1231 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.188 ng/ml |
Mouse nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0534MS-48T |
GenAsia Biotech |
48T |
EUR 403.2 |
Mouse nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0534MS-96T |
GenAsia Biotech |
96T |
EUR 640.8 |
Human nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0683HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human nuclear factor-κB p65(NF-κB p65)ELISA Kit |
GA-E0683HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Nuclear factor-κB p65(NF-κB p65)ELISA Kit |
YLA0732HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
Rabbit nuclear factor-κB p65,NF-κB p65 ELISA Kit |
GA-E0155RB-48T |
GenAsia Biotech |
48T |
EUR 391.2 |
Rabbit nuclear factor-κB p65,NF-κB p65 ELISA Kit |
GA-E0155RB-96T |
GenAsia Biotech |
96T |
EUR 628.8 |
Human Nuclear Factor Kappa B p65 (NF-κB p65) CLIA Kit |
abx196082-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human NF-κB p65(Nuclear Factor Kappa B p65) ELISA Kit |
EH3423 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
p65 antibody |
70R-21634 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal p65 antibody |
p65 Antibody |
32705-100ul |
SAB |
100ul |
EUR 302.4 |
p65 Antibody |
20-abx121814 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
p65 Antibody |
F46301-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB), which inactivates NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs. [OMIM] |
p65 Antibody |
F47588-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB), which inactivates NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs. [OMIM] |
p65 Antibody |
F47835-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB), which inactivates NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs. [OMIM] |
NF-κB p65 (pS529) Cell ELISA Kit |
abx595994-296tests |
Abbexa |
2 × 96 tests |
EUR 848.4 |
|
NF-κB p65 (pS311) Cell ELISA Kit |
abx596048-296tests |
Abbexa |
2 × 96 tests |
EUR 848.4 |
|
NF-κB p65 (pS536) Cell ELISA Kit |
abx596050-296tests |
Abbexa |
2 × 96 tests |
EUR 848.4 |
|
NF-κB p105/p50 Antibody |
48117-100ul |
SAB |
100ul |
EUR 399.6 |
NF-κB p105/p50 Antibody |
48117-50ul |
SAB |
50ul |
EUR 286.8 |
NF-κB p105/p50 Antibody |
48171-100ul |
SAB |
100ul |
EUR 399.6 |
NF-κB p105/p50 Antibody |
48171-50ul |
SAB |
50ul |
EUR 286.8 |
NF-κB p105/p50 Antibody |
48268-100ul |
SAB |
100ul |
EUR 399.6 |
NF-κB p105/p50 Antibody |
48268-50ul |
SAB |
50ul |
EUR 286.8 |
NFkB p65 antibody |
70R-11575 |
Fitzgerald |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal NFkB p65 antibody |
NFKB p65 antibody |
10R-1917 |
Fitzgerald |
100 ul |
EUR 457.2 |
Description: Mouse monoclonal NFKB p65 antibody |
NFkB p65 antibody |
10R-6718 |
Fitzgerald |
100 ug |
EUR 859.2 |
Description: Mouse monoclonal NFkB p65 antibody |
NFkB p65 antibody |
10R-7999 |
Fitzgerald |
100 ug |
EUR 630 |
Description: Mouse monoclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-36057 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-37450 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-37451 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-37452 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-37453 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal NFkB p65 antibody |
NFkB p65 antibody |
70R-37454 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal NFkB p65 antibody |
NFKP p65 antibody |
70R-34293 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal NFKP p65 antibody |
NFKP p65 antibody |
70R-34295 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal NFKP p65 antibody |
Electron transmission microscope shows that this structure represents the accumulation of large perinuclear proteins that may represent agresom. Our results show that HCMV manipulated UK1 and further components of the autophagic machine to ensure efficient virus particle release.